The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
All patients >/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
Non-anomalous singletons
Ability to provide informed consent
Patients with Type 1 diabetes
Patients with fetal major congenital abnormalities
Patients identified/referred after 30.6 weeks
The University of Texas Health Science Center, Houston
Lead sponsor
Smart Meter Corporation
Collaborator